Cardiovascular imaging in patients with chronic kidney disease

Blood Purification

Volumn 31, Issue 1-3, 2011, Pages 130-137

  Karohl, Cristina ^a,b   Raggi, Paolo ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

Calcification; Cardiovascular disease; Cardiovascular imaging; Chronic kidney disease

Indexed keywords

ARTERY CALCIFICATION; CARDIAC IMAGING; CHRONIC KIDNEY DISEASE; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; CONFERENCE PAPER; CORONARY ARTERY DISEASE; ECHOCARDIOGRAPHY; ECHOGRAPHY; ELASTICITY; ELECTRON BEAM TOMOGRAPHY; FUNCTION TEST; FUNCTIONAL ASSESSMENT; HEART MUSCLE BLOOD FLOW; HEMODIALYSIS PATIENT; HUMAN; MULTIDETECTOR COMPUTED TOMOGRAPHY; MYOCARDIAL PERFUSION IMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

CARDIAC IMAGING TECHNIQUES; CARDIOVASCULAR DISEASES; CARDIOVASCULAR SYSTEM; HUMANS; KIDNEY FAILURE, CHRONIC;

EID: 78651456857     PISSN: 02535068     EISSN: None     Source Type: Journal    
DOI: 10.1159/000321839     Document Type: Conference Paper

References (71)

1. Foley RN, Parfrey PS, Sarnak MJ: Epidemiology of cardiovascular disease in chronic renal disease. J Am Soc Nephrol 1998; 9:S16-S23.
2. Glassock RJ, Pecoits-Filho R, Barberato SH: Left ventricular mass in chronic kidney disease and ESRD. Clin J Am Soc Nephrol 2009; 4:S79-S91.
3. Kaupila LI, Polack JF, Cupples LA, Hannan MT, Kiel DP, Wilson PW: New indices to classify location, severity and progression of calcific lesions in the abdominal aorta: a 25- year follow-up study. Atherosclerosis 1997; 132: 245-250.
4. Adragão T, Pires A, Lucas C, Birne R, Magalhaes L, Gonçalves M, Negrão AP: A simple vascular calcification score predicts cardiovascular risk in haemodialysis patients. Nephrol Dial Transplant 2004; 19: 1480-1488.
5. London GM, Guérin AP, Marchais SJ, Métivier F, Pannier B, Adda H: Arterial media calcification in end-stage renal disease: Impact on all-cause and cardiovascular mortality. Nephrol Dial Transplant 2003; 18: 1731-1740.
6. Wilson PWF, Kaupila LI, O'Donnell CJ, Kiel DP, Hannan MT, Polack JF, Cupples LA: Abdominal aortic calcific deposits are an important predictor of vascular morbidity and mortality. Circulation 2001; 103: 1529-1534.
7. Walsh CR, Cupples LA, Levy D, Kiel DP, Hannan MT, Wilson PW, O'Donnell CJ: Abdominal aortic calcific deposits are associated with increased risk for congestive heart failure: The Framingham Heart Study. Am Heart J 2002; 144: 733-739.
8. Okuno S, Ishimura E, Kitatani K, Fujino Y, Kohno K, Maeno Y, Maekawa K, Yamakawa T, Imanishi Y, Inaba M, Nishizawa Y: Presence of abdominal aortic calcification is significantly associated with all-cause and cardiovascular mortality in maintenance hemodialysis patients. Am J Kidney Dis 2007; 49: 417-425.
9. Honkanen E, Kauppila L, Wikstrom B, Rensma PL, Krzesinski J, Aasarod K, Verbeke F, Jensen PB, Mattelaer P, Volck B: Abdominal aortic calcification in dialysis patients: results of the CORD study. Nephrol Dial Transplant 2008; 23: 4009-4015.
10. Stanford W, Thompson BH, Burns TL, Heery SD, Burr MC: Coronary artery calcium quantification at multi-detector row helical CT versus electron-beam CT. Radiology 2004; 230: 397-402.
11. Hurlock GS, Higashino H, Mochizuki T: History of cardiac computed tomography: Single to 320-detector row multislice computed tomography. Int J Cardiovasc Imaging 2009; 25: 31-42.
12. Agatston AS, Janowitz WR, Hildner FJ, Zusmer NR, Viamonte MJ, Detrano R: Quantification of coronary artery calcium using ultrafast computed tomography. J Am Coll Cardiol 1990; 15: 827-832.
13. Callister TQ, Cooil B, Raya SP, Lippolis NJ, Russo DJ, Raggi P: Coronary artery disease: improved reproducibility of calcium scoring with an electron-beam CT volumetric method. Radiology 1998; 208: 807-814.
14. Rumberger JA, Kaufman L: A rosetta stone for coronary calcium risk stratification: Agatston, volume, and mass scores in 11,490 individuals. AJR Am J Roentgenol 2003; 181: 743-748.
15. Rosen BD, Fernandes V, McClelland RL, Carr JJ, Detrano R, Bluemke DA, Lima JAC: Relationship between baseline coronary calcium score and demonstration of coronary artery stenoses during follow-up. JACC Cardiovasc Imaging 2009; 2: 1175-1183.
16. Haydar AA, Hujairi NMA, Covic AA, Pereira D, Rubens M, Goldsmith DJA: Coronary artery calcification is related to coronary atherosclerosis in chronic renal disease patients: a study comparing EBCT-generated coronary artery calcium scores and coronary angiography. Nephrol Dial Transplant 2004; 19: 2307-2312.
17. Braun J, Oldendorf M, Moshage W, Heidler R, Zeitler E, Luft FC: Electron beam computed tomography in the evaluation of cardiac calcification in chronic dialysis patients. Am J Kidney Dis 1996; 27: 394-401.
18. Goodman WG, Goldin J, Kuizon BD, Yoon C, Gales B, Sider D, Wang Y, Chung J, Emerick A, Greaser L, Elashoff RM, Saluski IB: Coronary-artery calcification in young adults with end-stage renal disease who are undergoing dialysis. N Engl J Med 2000; 342: 1478-1483.
19. Kramer H, Toto R, Peshock R, Cooper R, Victor R: Association between chronic kidney disease and coronary artery calcification: The DALLAS Heart Study. J Am Soc Nephrol 2005; 16: 507-513. (Pubitemid 41725148)
20. Chertow GM, Burke SK, Raggi P: Sevelamer attenuates the progression of coronary and aortic calcification in hemodialysis patients. Kidney Int 2002; 62: 245-252.
21. Matsuoka M, Iseki K, Tamashiro M, Fujimoto N, Higa N, Touma T, Takishita S: Impact of high coronary artery calcification score (CACS) on survival in patients on chronic hemodialysis. Clin Exp Nephrol 2004; 8: 54-58.
22. Sigrist M, Bungay P, Taal MW, McIntyre CW: Vascular calcification and cardiovascular function in chronic kidney disease. Nephrol Dial Transplant 2006; 21: 707-714.
23. Garland JS, Holden RM, Groome PA, Lam M, Nolan RL, Morton AR, Pickett W: Prevalence and association of coronary artery calcification in patients with stages 3 to 5 CKD without cardiovascular disease. Am J Kidney Dis 2008; 52: 849-858.
24. Adeney KL, Siscovick DS, Ix JH, Seliger SL, Shlipak MG, Jenny NS, Kestenbaum BR: Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol 2009; 20: 381-387.
25. Russo D, Palmiero G, De Blasio AP, Balletta MM, Andreucci VE: Coronary artery calcification in patients with CRF not undergoing dialysis. Am J Kidney Dis 2004; 44: 1024-1030.
26. Block GA, Raggi P, Bellasi A, Kooienga L, Spiegel DM: Mortality effect of coronary calcification and phosphate binder choice in incident hemodialysis patients. Kidney Int 2007; 71: 438-441.
27. Russo D, Morrone LF, Brancaccio S, Napolitano P, Salvatore E, Spadola R, Imbriaco M, Russo CV, Andreucci VE: Pulse pressure and presence of coronary artery calcification. Clin J Am Soc Nephrol 2009; 4: 316-322.
28. Shantouf RS, Budoff MJ, Ahmadi N, Ghaffari A, Flores F, Gopal A, Noori N, Jing J, Kovesdy CP, Kalantar-Zadeh K: Total and individual coronary artery calcium scores as independent predictors of mortality in hemodialysis patients. Am J Nephrol 2010; 31: 419-425.
29. Block GA, Spiegel DM, Ehrlich J, Mehta R, Lindbergh J, Dreisbach A, Raggi P: Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis. Kidney Int 2005; 68: 1815-1824.
30. Barreto DV, Barreto FC, Carvalho AB, Cuppari L, Draibe SA, Dalboni MA, Moyses RM, Neves KR, Jorgetti V, Miname M, Santos RD, Canziani MEF: Phosphate binder impact on bone remodeling and coronary calcificationresults from the BRIC study. Nephron Clin Pract 2008; 110:c273-c283.
31. Qunibi W, Moustafa M, Muenz LR, He DY, Kessler PD, Diaz-Buxo JA, Budoff M: A 1-year randomized trial of calcium acetate versus sevelamer on progression of coronary artery calcification in hemodialysis patients with comparable lipid control: The Calcium Acetate Renagel Evaluation-2 (CARE-2) study. Am J Kidney Dis 2008; 51: 952-965.
32. Floege J, Raggi P, Block GA, Torres PU, Csiky B, Naso A, Nossuli K, Moustafa M, Goodman WG, Lopez N, Downey G, Dehmel B, Chertow GM: Study design and subject baseline characteristic in the ADVANCE study: effects of cinacalcet on vascular calcification in haemodialysis patients. Nephrol Dial Transplant 2010; 25: 1916-1923.
33. Bellasi A, Ferramosca E, Muntner P, Ratti C, Wildman RP, Block GA, Raggi P: Correlation of simple imaging tests and coronary artery calcium measured by computed tomography in hemodialysis patients. Kidney Int 2006; 70: 1623-1628.
34. Raggi P, Bellasi A, Ferramosca E, Islam T, Muntner P, Block GA: Association of pulse wave velocity with vascular and valvular calcification in hemodialysis patients. Kidney Int 2007; 71: 802-807. (Pubitemid 46624028)
35. Stompór T, Rajzer M, Pasowicz M, Krasniak A, Sulowicz W, Kawecka-Jaszcz K, Tracz W, Janda K, Tabor B, Kowalczyk-Michalek ME, Wójcik K, Konieczynska M, Klimeczek P, Janusz- Grzybowska E: Coronary artery calcification, common carotid artery intima-media thickness and aortic pulse wave velocity in patients on peritoneal dialysis. Int J Artif Organs 2006; 29: 736-744.
36. Hurst RT, Ng DW, Kendall C, Khandheria B: Clinical use of carotid intima-media thickness: review of the literature. J Am Soc Echocardiogr 2007; 20: 907-914.
37. Kawamoto R, Ohtsuka N, Kusunoki T, Yorimitsu N: An association between the estimated glomerular filtration rate and carotid atherosclerosis. Intern Med 2008; 47: 391-398. (Pubitemid 351663689)
38. Oh J, Wunsch R, Turzer M, Bahner M, Raggi P, Querfeld U, Mehls O, Schaefer F: Advanced coronary and carotid arteriopathy in young adults with childhood-onset chronic renal failure. Circulation 2002; 106: 100-105.
39. Delucchi A, Dinamarca H, Gainza H, Whitttle C, Torrealba I, Iñiguez G: Carotid intimamedia thickness as a cardiovascular risk marker in pediatric end-stage renal disease patients on dialysis and in renal transplantation. Transplant Proc 2008; 40: 3244-3246.
40. Kocak H, Gumuslu S, Sahin E, Ceken K, Ermis C, Gocmen AY, Yakupoglu G, Ersoy FF, Suleymanlar G, Tuncer M: Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilatation in peritoneal dialysis patients. Int Urol Nephrol 2009; 41: 409-416.
41. Benedetto FA, Tripepi G, Mallamaci F, Zoccali C: Rate of atherosclerotic plaque formation predicts cardiovascular events in ESRD. J Am Soc Nephrol 2008; 19: 757-763.
42. Szeto CC, Chow KM, Woo KS, Chook P, Kwan BC, Leung CB, Li PK: Carotid intima media thickness predicts cardiovascular diseases in Chinese predialysis patients with chronic kidney disease. J Am Soc Nephrol 2007; 18: 1966-1972.
43. Zoungas S, Cameron JD, Kerr PG, Wolfe R, Muske C, McNeil JJ, McGrath BP: Association of carotid intima-medial thickness and indices of arterial stiffness with cardiovascular disease outcomes in CKD. Am J Kidney Dis 2007; 50: 622-630.
44. Kurnatowska I, Grzelak P, Stefanczyk L, Nowicki M: Tight relations between coronary calcification and atherosclerotic lesions in the carotid artery in chronic dialysis patients. Nephrology (Carlton) 2010; 15: 184-189.
45. Enderle MD, Schroeder S, Ossen R, Meisner C, Baumbach A, Haering HU, Karsch KR, Pfohl M: Comparison of peripheral endothelial dysfunction and intimal media thickness in patients with suspected coronary artery disease. Heart 1998; 80: 349-354.
46. Yan RT, Anderson TJ, Charbonneau F, Title L, Verma S, Lonn E: Relationship between carotid artery intima-media thickness and brachial artery flow-mediated dilation in middle-aged healthy men. J Am Coll Cardiol 2005; 45: 1980-1986.
47. Lemos MM, Jancikic AD, Sanches FM, Christofalo DM, Ajzen SA, Miname MH, Santos RD, Fachini FC, Carvalho AB, Draibe SA, Canziani MEF: Pulse wave velocity - a useful tool for cardiovascular surveillance in pre-dialysis patients. Nephrol Dial Transplant 2007; 22: 3527-3532.
48. Nikitin NP, Constantin C, Loh PH, Ghosh J, Lukaschuk EI, Bennett A, Hurren S, Alamgir F, Clark AL, Cleland JG: New generation 3-dimensional echocardiography for left ventricular volumetric and functional measurements: comparison with cardiac magnetic resonance. Eur J Echocardiogr 2006; 7: 365-372.
49. Tripepi G, Benedetto FA, Mallamaci F, Tripepi R, Malatino L, Zoccali C: Left atrial volume in end-stage renal disease: a prospective cohort study. J Hypertens 2006; 24: 1173-1180.
50. Sharma R, Pellerin D, Gaze DC, Gregson H, Streather CP, Collinson PO, Brecker SJD: Dobutamine stress echocardiography and the resting but not exercise electrocardiograph predict severe coronary artery disease in renal transplant candidates. Nephrol Dial Transplant 2005; 20: 2207-2214. (Pubitemid 41510099)
51. Tita C, Karthikeyan V, Stroe A, Jacobsen G, Ananthasubramaniam K: Stress echocardiography for risk stratification in patients with end-stage renal disease undergoing renal transplantation. J Am Soc Nephrol 2008; 21: 321-326.
52. Wang AY, Wang M, Woo J, Lam CW, Li PK, Lui SF, Sanderson JE: Cardiac valve calcification as an important predictor for all-cause mortality and cardiovascular mortality in long-term peritoneal dialysis patients: a prospective study. J Am Soc Nephrol 2003; 14: 159-168.
53. Stewart GA, Foster JE, Cowan M, Rooney E, McDonagh T, Dargie HJ, Rodger RS, Jardine AG: Echocardiography overestimates left ventricular mass in hemodialysis patients relative to magnetic resonance imaging. Kidney Int 1999; 56: 2248-2253.
54. Moran A, Katz R, Jenny NS, Astor B, Bluemke DA, Lima JAC, Siscovick DS, Bertoni AG, Shlipak MG: Left ventricular hypertrophy in mild and moderate chronic kidney disease determined using cardiac magnetic resonance imaging and cystatin C: The Multi- Ethnic Study of Atherosclerosis. Am J Kidney Dis 2008; 52: 839-848.
55. Patel RK, Oliver S, Mark PB, Powell JR, Mc- Quarrie EP, Traynor JP, Dargie HJ, Jardine AG: Determinants of left ventricular mass and hypertrophy in hemodialysis patients assessed by cardiac magnetic resonance imaging. Clin J Am Soc Nephrol 2009; 4: 1477-1483.
56. McGill RL, Biederman RWW, Getts RT, Hazlett SM, Sharma SB, Duran J, Brandys DE, Sysak JC, Sureshkumar KK, Sandroni SE, Marcus RJ: Cardiac magnetic resonance imaging in hemodialysis patients. J Nephrol 2009; 22: 367-372.
57. Edwards NC, Steeds RP, Stewart PM, Ferro CJ, Townend JN: Effect of spironolactone on left ventricular mass and aortic stiffness in early-stage chronic kidney disease: a randomized controlled trial. J Am Coll Cardiol 2009; 54: 505-512.
58. Andrade JM, Gowdak LHW, Giorgi MCP, Paula FJ, Kalil-Filho R, Lima JJG, Rochitte CE: Cardiac MRI for detection of unrecognized myocardial infarction in patients with end-stage renal disease: comparison with ECG and scintigraphy. AJR 2009; 193:W25-W32.
59. Hasebroock KM, Serkova NJ: Toxicity of MRI and CT contrast agents. Expert Opin Drug Metab Toxicol 2009; 5: 403-416.
60. Mark PB, Doyle A, Blyth KG, Patel RK, Weir RAP, Steedman T, Foster JE, Dargie HJ, Jardine AG: Vascular function assessed with cardiovascular magnetic resonance predicts survival in patients with advanced chronic kidney disease. J Cardiovasc Magn Reson 2008; 10: 39.
61. Hase H, Joki N, Ishikawa H, Saijyo T, Tanaka Y, Takahashi Y, Inishi Y, Imamura Y, Nakamura M, Moroi M: Independent risk factors for progression of coronary atherosclerosis in hemodialysis patients. Ther Apher Dial 2006; 10: 321-327. (Pubitemid 44154761)
62. Momose M, Babazono T, Kondo C, Kobayashi H, Nakajima T, Kusakabe K: Prognostic significance of stress myocardial ECG-gated perfusion imaging in asymptomatic patients with diabetic chronic kidney disease on initiation of haemodialysis. Eur J Nucl Med Mol Imaging 2009; 36: 1315-1321.
63. Hatta T, Nishimura S, Nishimura T: Prognostic risk stratification of myocardial ischaemia evaluated by gated myocardial perfusion SPECT in patients with chronic kidney disease. Eur J Nucl Med Mol Imaging 2009; 36: 1835-1841.
64. K/DOQI clinical practice guidelines for cardiovascular disease in dialysis patients. Am J Kidney Dis 2005; 45:S1-S153.
65. Townsend RR, Wimmer NJ, Chirinos JA, Parsa A, Weir M, Perumal K, Lash JP, Chen J, Steigerwalt SP, Flack J, Go AS, Rafey M, Rahman M, Sheridan A, Gadegbeku CA, Robinson NA, Joffe M: Aortic PWV in chronic kidney disease: a CRIC ancillary study. Am J Hypertens 2010; 23: 282-289.
66. Sengstock D, Sands RL, Gillespie BW, Zhang X, Kiser M, Eisele G, Vaitkevicius P, Kuhlmann M, Levin NW, Hinderliter A, Rajagopalan S, Saran R: Dominance of traditional cardiovascular risk factors over renal function in predicting arterial stiffness in subjects with chronic kidney disease. Nephrol Dial Transplant 2010; 25: 853-861.
67. Wang MC, Tsai WC, Chen JY, Huang JJ: Stepwise increase in arterial stiffness corresponding with the stages of chronic kidney disease. Am J Kidney Dis 2005; 45: 494-501.
68. Adragão T, Pires A, Birne R, Curto JD, Lucas C, Gonçalves M, Negrão AP: A plain X-ray vascular calcification score is associated with arterial stiffness and mortality in dialysis patients. Nephrol Dial Transplant 2009; 24: 997-1002.
69. Blacher J, Guerin AP, Pannier B, Marchais SJ, Safar ME, London GM: Impact of aortic stiffness on survival in end-stage renal disease. Circulation 1999; 99: 2434-2439.
70. Guérin AP, Blacher J, Pannier B, Marchais SJ, Safar ME: Impact of aortic stiffness attenuation on survival of patients in end-stage renal failure. Circulation 2001; 103: 987-992.
71. KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of chronic kidney disease - mineral and bone disorder (CKD-MBD). Kidney Int 2009; 113:S1-S130.